AusCann announced it has chosen Aspen Pharmacare Australia to provide packaging for its medicinal cannabis pharmaceutical products.
On Monday (November 25), AusCann Group Holdings Limited (ASX:AC8) announced it tagged TGA-licensed Aspen Pharmacare Australia to provide packaging for its medicinal cannabis pharmaceutical products.
As quoted in the press release:
The appointment of Aspen derives from AusCann’s careful management of its supply chain and cost base, and aims to de-risk the supply chain in the most cost effective manner, ensure quality compliance, and follows similar partnerships with cultivation & extraction, manufacturing, and controlled distribution service providers. The agreement with Aspen is for an initial three year period that can be extended and will include GMP packaging services for AusCann’s proprietary solid hard shell capsules. These will be manufactured under contract by AusCann’s manufacturing partner, PCI Pharma, and will be packaged by Aspen in consumer ready packs at its Australian facility. This agreement is the result of a detailed financial analysis that indicated a considerable cost benefit for packaging outsourcing with Aspen.